Enhanced Liver Fibrosis (ELF) Test
Also called ELF score
A blood panel combining three markers of extracellular matrix turnover to estimate liver fibrosis — actual scarring, not just enzyme leakage.
- Lab price$250.00
- RetestAnnually if elevated or at risk
Normal is not optimal
ALT and AST tell you about inflammation; they don't tell you about scarring. Someone can have normal enzymes with significant fibrosis.
- Standard
- ELF score <7.7 low risk · 7.7–9.8 moderate · ≥9.8 higher risk of advanced fibrosis
- Optimal
- Sameunder 9.80 prognostically, under 7.7 on the staging bands.
- Standard
- ELF score <7.7 low risk · 7.7–9.8 moderate · ≥9.8 higher risk of advanced fibrosis
- Optimal
- Under 9.80on the prognostic risk bands US reports use. Under 7.7 is the separate none-to-mild fibrosis staging band.
Order it yourself
One test, drawn at a Quest lab near you. The price is the lab’s, from Marek’s own menu.
Code CAMERON takes 10% off. Marek’s checkout adds its one-time blood-draw fee to individual tests and shows the total before you pay.
Order it with Comprehensive Metabolic Panel (CMP) and Fasting Insulin (3 tests, one cart)
What moves Enhanced Liver Fibrosis (ELF) Test
Non-alcoholic fatty liver disease (by far the most common), alcohol, viral hepatitis, long-term oral 17-alpha-alkylated androgen use, and autoimmune liver disease.
If it’s high: Suggests significant fibrosis — warrants hepatology evaluation and imaging (FibroScan/elastography).
If it’s low: Reassuring, particularly with normal enzymes.

The free Before‑You‑Stack Lab Kit
The 12 labs I’d run before any protocol, what each one tells you, add-ons by goal and how to order them yourself. The PDF is yours straight away.
After that it is about two emails a week: a marker, a compound or a protocol. Unsubscribe in one click.
Everything else about Enhanced Liver Fibrosis (ELF) Test
What can skew the result
2 things can change the reading or the real level
Some change your real level; others only change the reading. Each one says which, and what to do about it.
- Acute illness or infectionPhysiological state
This is an acute-phase reactant — it moves substantially during any infection, injury or inflammatory episode, and the change has nothing to do with your baseline.
Do this: Wait two weeks after any illness, vaccination or injury before drawing or interpreting.
A real change — retest once it passes- AgePhysiological state
ELF score rises with age independently of fibrosis, so thresholds validated in one age group over-call in older people.
Do this: Interpret against an age-aware threshold.
A real change — retest once it passes
Symptoms it helps explain
1 symptom, and which to test first
Then worth checking for
- Liver concerns, or I drink more than I'd like
Plan of attack
What to do, in this order
- Confirm the number is real
Acute illness or infection. This is an acute-phase reactant — it moves substantially during any infection, injury or inflammatory episode, and the change has nothing to do with your baseline. Wait two weeks after any illness, vaccination or injury before drawing or interpreting.
- Read it with its partner
A more meaningful liver test than ALT for long-term risk. Pair with imaging. Draw it alongside: Comprehensive Metabolic Panel (CMP), GGT (Gamma-Glutamyl Transferase), Fasting Insulin.
- Work out which direction is yours
If it's high — Suggests significant fibrosis — warrants hepatology evaluation and imaging (FibroScan/elastography).
If it's low — Reassuring, particularly with normal enzymes. - Fix it in order: food, then cause, then everything else
Nutrition. Fat loss is the only proven treatment for NAFLD — even 5–10% body weight reduction meaningfully reduces liver fat, and 10%+ can improve fibrosis. Cut fructose and alcohol; increase protein and fiber.
Lifestyle. Eliminate alcohol entirely if fibrosis is present. Exercise independently reduces liver fat even without weight loss. - Retest
Annually if elevated or at risk. Change one thing at a time, or the retest can't tell you which thing worked.
Where the optimal range comes from
Outcome-anchored optimum
Outcome-anchored optimum. A target drawn from what happened to people at that level — not from the middle of a lab's reference population.
- The number
- Under 9.80 is the lower-risk band on the US-reported scale; 9.80–11.29 mid risk; above 11.29 higher risk. The original manufacturer bands also describe under 7.7 as none-to-mild fibrosis, which is where the '<7.7' figure quoted around the internet comes from.
- Measured in
- Adults tested for liver fibrosis; the risk bands are prognostic rather than diagnostic.
- Anchored to
- Likelihood of progression to cirrhosis and liver-related clinical events within 3.9 years of the baseline score.
- Source
- Enhanced Liver Fibrosis (ELF) test information, Labcorp assay documentation.
The site previously printed <7.7 as the optimal target with no explanation of which scale that belongs to. Both scales are real and they answer different questions: 7.7 marks the bottom of the fibrosis staging bands, 9.80 and 11.29 mark the prognostic risk bands the US report uses. The ELF score is unitless, so it cannot be sanity-checked against anything — read it against the bands printed on your own report and nothing else.
What Enhanced Liver Fibrosis (ELF) Test measures
And why people check it
What it tells you
A blood panel combining three markers of extracellular matrix turnover to estimate liver fibrosis — actual scarring, not just enzyme leakage.
Why people check it
ALT and AST tell you about inflammation; they don't tell you about scarring. Someone can have normal enzymes with significant fibrosis. Genuinely important for anyone with fatty liver, heavy alcohol history, or years of oral compound use.
What Enhanced Liver Fibrosis (ELF) Test means next to other markers
1 pattern worth knowing
- Raised ELF score — fibrosis, but read it against age
ELF raised · liver enzymes may be normal
ELF estimates fibrosis rather than inflammation, which is why it can be abnormal with perfectly normal ALT and AST — enzymes reflect ongoing damage, fibrosis reflects accumulated scarring. But ELF also rises with age independently, so thresholds validated in one age group over-call in older people.
Interpret against an age-aware threshold and alongside imaging. A raised ELF is a hepatology conversation, not a supplement one.
Panels that carry Enhanced Liver Fibrosis (ELF) Test
2 panels, prices with code CAMERON
Read it alongside
Related markers, goals and what moves it in the library
Related markers
Goals it helps decide
In the library: what moves it
The deep read, with sources
What the Enhanced Liver Fibrosis (ELF) Test actually measures, and the references
What Enhanced Liver Fibrosis (ELF) Test actually measures — the analyte, and the assay
The ELF score is not a measurement of your liver. It is an algorithm applied to three measurements of extracellular matrix turnover anywhere in your body. The three analytes are hyaluronic acid, procollagen III amino-terminal peptide and tissue inhibitor of metalloproteinase 1, each measured by immunoassay on one manufacturer's platform and then combined in a proprietary logarithmic discriminant function to give a single unitless number.
Two design facts follow from that and both are load-bearing. First, the score is platform-locked: there is no reference measurement procedure for ELF, no certified reference material, and no way to reproduce the number on another analyzer. Second, none of the three analytes is liver-specific. Hyaluronic acid is synthesized by fibroblasts throughout the body; PIIINP is released wherever type III collagen is being laid down; TIMP-1 regulates matrix turnover generally.
What makes the combination work in liver disease is a second mechanism layered on the first. Hyaluronic acid is cleared by hepatic sinusoidal endothelial cells, so in a scarred liver the same molecule rises for two reasons at once — more is being made and less is being removed. That double sensitivity is why the score performs, and it is also why it is hard to interpret in anyone with a reason for systemic matrix turnover.
The performance is real and it has been quantified. Among 829 patients with nonalcoholic fatty liver disease, mean ELF was 10.1 (SD 1.3) in those with advanced fibrosis against 8.6 (1.0) without, and the area under the receiver operating characteristic curve for identifying advanced fibrosis was 0.81 (95% CI 0.77–0.85) against biopsy and 0.79 (0.75–0.82) against transient elastography Younossi 2021.
Enhanced Liver Fibrosis (ELF) Test: what changes the blood, and what only changes the reading
What changes the score for hepatic reasons:
- Active hepatic fibrogenesis. The intended signal — matrix being laid down, which is a different event from the presence of old scar.
- Reduced hepatic sinusoidal clearance of hyaluronic acid, which rises as architecture is lost and amplifies the signal.
- Active hepatic inflammation, which drives matrix turnover without necessarily meaning permanent scarring — so an ELF drawn during a flare of any hepatitis overstates the fibrosis stage.
What changes the score for reasons that have nothing to do with your liver — and this list is longer than the one above:
- Age. Hyaluronic acid and PIIINP both rise with age in people with normal livers, so an older reader starts higher. This is the single largest non-hepatic term and it is why thresholds validated in one age band travel badly Vali 2025.
- Any systemic inflammatory or fibrotic disease. Rheumatoid arthritis, systemic sclerosis, inflammatory bowel disease and active infection all raise matrix turnover markers.
- Recent food. Serum hyaluronic acid rises postprandially. Draw it fasting, which almost nobody is told.
- Heavy eccentric training and acute muscle remodeling, which is connective-tissue turnover by definition.
- Extrahepatic malignancy and heart failure, both upward.
- Impaired lymphatic drainage, which raises hyaluronic acid.
What changes only the reading: which platform ran it, since there is no harmonization to appeal to; and which threshold set the report applied, which is a reporting choice rather than a measurement Vali 2025.
Reference interval or decision threshold — which kind of number Enhanced Liver Fibrosis (ELF) Test is
Risk bands, not a reference interval — and the bands are not the same in every country or every clinic. Nobody sampled healthy people and took the middle 95%. The published cut-points were chosen to separate patients with advanced fibrosis from patients without, in a particular population, at a particular prevalence.
Which means the threshold depends on who is being tested, and this has now been shown directly. Across a metacohort of 586 patients with metabolic dysfunction-associated steatotic liver disease, diagnostic accuracy varied by subgroup and different thresholds were needed in different subgroups to achieve comparable performance Vali 2025. A single printed cut-off is a simplification of a test whose correct cut-off is a function of your age, your diabetes status and your pre-test probability.
The rule-in and rule-out numbers are worth stating properly, because they are far more useful than a band. In the 829-patient fatty liver cohort, an ELF of 7.2 or greater combined with a FIB-4 of 0.74 or greater gave a negative predictive value of 95.1% (95% CI 91.8–98.4) and a sensitivity of 92.5% (87.4–97.5) — that is the rule-out. An ELF of 9.8 or greater with a FIB-4 of 2.9 or greater gave a positive predictive value of 95.0% (85.5–100) and a specificity of 99.7% (99.1–100) — that is the rule-in Younossi 2021. Note that both are pairs: the sequential use of the free score first and the paid score second is the validated pathway, not ELF alone Kang 2024.
A score of 9.5 is therefore neither reassuring nor alarming on its own. It is a number that needs a FIB-4, an age and a risk profile next to it before it means anything.
How you would know your Enhanced Liver Fibrosis (ELF) Test was wrong — and when to redraw
Twelve months, and the reason is that fibrosis remodels over years. Collagen deposition and resorption in the liver are slow processes; there is no intervention that changes fibrosis stage in six weeks, so a six-week repeat measures analytical noise and the postprandial state, not your liver.
Conditions that must match: fasting, every time, because hyaluronic acid moves after a meal; the same platform; no acute inflammatory illness in the preceding month; no heavy eccentric training in the preceding week; and stable treatment for any systemic inflammatory disease.
What would have to change for the retest to mean something. ELF should move with its neighbors or not at all. The confirmatory set is FIB-4 (which needs only age, ALT, AST and platelets, and is therefore free), platelet count (falling platelets are one of the earliest signs of portal hypertension), and transient elastography. A rising ELF with a stable FIB-4, stable platelets and stable liver stiffness is much more likely to be age, inflammation or extrahepatic matrix turnover than progressing fibrosis Kang 2024 Vali 2025.
How you would know the value was wrong. An isolated raised ELF in someone with no metabolic risk factors, no alcohol history, normal platelets, a low FIB-4 and normal elastography is more likely to be reporting something other than the liver. Before accepting it, check that the sample was fasting, ask what else in the body is remodeling connective tissue, and repeat it rather than escalating to biopsy.
What Enhanced Liver Fibrosis (ELF) Test cannot tell you
It cannot stage fibrosis. It estimates the probability that advanced fibrosis is present. It does not tell you F2 from F3, and the underlying histological stages are ordinal categories that a continuous score approximates rather than reproduces Younossi 2021.
It cannot tell steatohepatitis from bland steatosis. Fat with inflammation and fat without it are different diseases with different trajectories, and ELF does not separate them.
It cannot tell you the cause. Alcohol, metabolic dysfunction, viral hepatitis, autoimmune disease and years of oral 17-alpha-alkylated androgens all produce fibrosis, and all produce the same rising number.
Its positive predictive value collapses in low-prevalence populations. The 95.0% positive predictive value quoted above came from a liver clinic where a quarter of biopsied patients had bridging fibrosis or cirrhosis Younossi 2021. Applied to a healthy gym population where advanced fibrosis is rare, the same cut-off produces mostly false positives — which is arithmetic, not a flaw in the test, and it is the reason the sequential FIB-4-first pathway exists Kang 2024.
A normal ELF does not exclude fibrosis in a high-risk person. The 95.1% negative predictive value is also prevalence-dependent, and in 59 diabetics with normal transaminases 12% still had stage F3 or F4 disease Makker 2021.
The wrong inference readers actually draw is that ELF replaces the liver enzymes because it measures something deeper. It answers a different question, later. The enzymes report current hepatocellular stress — and their reference intervals are themselves set too high Valenti 2021 Choi 2024 Li 2025. ELF reports accumulated matrix change. Someone with an ALT of 45 U/L and an ELF of 8.0 has an active problem and not yet a structural one, and that is precisely the window in which fat loss still reverses it.
Sources read for these sections
- Younossi ZM, et al. Performance of the Enhanced Liver Fibrosis Test to Estimate Advanced Fibrosis Among Patients With Nonalcoholic Fatty Liver Disease. JAMA Network Open 2021 · PMID 34529067
- Vali Y, et al. Precision in Liver Diagnosis: Varied Accuracy Across Subgroups and the Need for Variable Thresholds in Diagnosis of MASLD. Liver International 2025 · PMID 39865358
- Kang YW, et al. Sequential Diagnostic Approach Using FIB-4 and ELF for Predicting Advanced Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease. Diagnostics 2024 · PMID 39594183
- Makker J, et al. Prevalence of advanced liver fibrosis and steatosis in type-2 diabetics with normal transaminases: A prospective cohort study. World Journal of Gastroenterology 2021 · PMID 33642826
- Valenti L, et al. Definition of Healthy Ranges for Alanine Aminotransferase Levels: A 2021 Update. Hepatology Communications 2021 · PMID 34520121
- Choi J, et al. Updated Reference Intervals for Alanine Aminotransferase in a Metabolically and Histologically Normal Population. Clinical Gastroenterology and Hepatology 2024 · PMID 38750867
- Li Q, et al. Association between De-Ritis ratio (AST/ALT) and mortality in patients with chronic kidney disease: a retrospective cohort study. Scientific Reports 2025 · PMID 40113904
Enhanced Liver Fibrosis (ELF) Test questions
6 answered
- What is a normal Enhanced Liver Fibrosis (ELF) Test level?
- Women: ELF score <7.7 low risk · 7.7–9.8 moderate · ≥9.8 higher risk of advanced fibrosis. Men: ELF score <7.7 low risk · 7.7–9.8 moderate · ≥9.8 higher risk of advanced fibrosis. Ranges vary by laboratory and assay; always compare to the range printed on your own report.
- What is the optimal Enhanced Liver Fibrosis (ELF) Test level?
- Women: Same — under 9.80 prognostically, under 7.7 on the staging bands. Men: Under 9.80 on the prognostic risk bands US reports use. Under 7.7 is the separate none-to-mild fibrosis staging band. Enhanced Liver Fibrosis (ELF) test information, Labcorp assay documentation.
- What does a high Enhanced Liver Fibrosis (ELF) Test mean?
- Suggests significant fibrosis — warrants hepatology evaluation and imaging (FibroScan/elastography).
- What does a low Enhanced Liver Fibrosis (ELF) Test mean?
- Reassuring, particularly with normal enzymes.
- How often should I retest Enhanced Liver Fibrosis (ELF) Test?
- Annually if elevated or at risk.
- How do I test Enhanced Liver Fibrosis (ELF) Test?
- Through Marek Diagnostics without a doctor's visit, drawn at a Quest Diagnostics location in the US. Code CAMERON applies 10% off automatically through the links on this page.
Sources: NICE guideline NG49 — ELF test for advanced liver fibrosis in NAFLD.
The Fatty Liver & Liver Health protocol is a lesson in Skool
This page tells you what the number means and the order to act in. Skool is where it becomes a plan for your situation, read against your own labs.
- The full Fatty Liver & Liver Health protocol, step by step
- Supplement form, timing and how long to run it
- The hormones and compounds that move it, and what to watch
5.0 (15 reviews)1,500+ members

Want it built around you?
Educational and research purposes only. Not medical advice; talk to your clinician about results. Lab ranges vary by assay and laboratory: compare against the range printed on your own report. Some links are affiliate links; Cam may earn a commission at no extra cost to you. Medical disclaimer and affiliate disclosure